stock.name

Dynavax Technologies Corp.

DVAX

Market Cap$1.57B
Close$

Compare Dynavax Technologies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Dynavax Technologies Corp.Dynavax Technologies Corp.-246.10%-1%12.40.4
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$18.76

Current Fair Value

51.2% upside

Undervalued by 51.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.57 Billion
Enterprise Value$1.05 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.05
Beta0.63
Outstanding Shares129,300,000
Avg 30 Day Volume2,228,192

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-246.09
PEG246.89
Price to Sales12.41
Price to Book Ratio3.1
Enterprise Value to Revenue4.53
Enterprise Value to EBIT-27.68
Enterprise Value to Net Income-165
Total Debt to Enterprise0.21
Debt to Equity0.36

Revenue Sources

No data

ESG Score

No data

About Dynavax Technologies Corp.

CEO: Ryan Spencer